Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Other Operating Expenses (2020 - 2025)

Biofrontera has reported Other Operating Expenses over the past 6 years, most recently at $3.2 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 135.9% year-over-year to $3.2 million; the TTM value through Dec 2025 reached $24.2 million, up 78.72%, while the annual FY2025 figure was $11.6 million, 37.89% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $3.2 million at Biofrontera, down from $6.9 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $13.4 million in Q3 2023 and troughed at -$9.0 million in Q4 2024.
  • A 5-year average of $4.0 million and a median of $4.0 million in 2021 define the central range for Other Operating Expenses.
  • On a YoY basis, Other Operating Expenses climbed as much as 6741.33% in 2023 and fell as far as 168.13% in 2023.
  • Year by year, Other Operating Expenses stood at $1.8 million in 2021, then soared by 206.86% to $5.7 million in 2022, then tumbled by 168.13% to -$3.9 million in 2023, then crashed by 132.78% to -$9.0 million in 2024, then soared by 135.9% to $3.2 million in 2025.
  • Business Quant data shows Other Operating Expenses for BFRI at $3.2 million in Q4 2025, $6.9 million in Q3 2025, and $6.8 million in Q2 2025.